STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
Event: Stephens Annual
Management Attendee:
Date:
Time:
Location: Live Webcast
The live webcast link includes an option to pre-register. An online replay of the webcast will also be available on STAAR’s investor website at https://investors.staar.com/.
About
STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113681040/en/
Investors & Media
Vice President, Investor Relations and Corporate Development
(626) 303-7902, Ext. 3023
bmoore@staar.com
Director, Investor Relations and HPMS
(626) 303-7902, Ext. 2207
cjohnson@staar.com
Source: